Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 7.27B 1.08B 933M 872M 797M 1.5B 103B 1.53B 10.23B 4.01B 51.44B 4.05B 3.96B 171B P/E 2026 *
12.6x
P/E 2027 * 10.6x
Enterprise Value 5.93B 880M 761M 712M 650M 1.23B 83.89B 1.24B 8.35B 3.27B 41.97B 3.3B 3.23B 140B EV / Sales 2026 *
0.33x
EV / Sales 2027 * 0.29x
Free-Float
51.88%
Yield 2026 *
4.04%
Yield 2027 * 4.55%
1 day+3.35%
1 week-0.42%
Current month+0.60%
1 month+16.01%
3 months-8.14%
6 months-16.68%
Current year-8.71%
1 week 11.08
Extreme 11.08
11.98
1 month 10.1
Extreme 10.1
11.98
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
15.66
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
11/5/26 Buy

Founder

4,371,400 1.0926%
18/12/25 Buy

Founder

1,550,700 0.3876%
17/12/25 Buy

Founder

2,004,500 0.5010%
Change 5-day change 1-year change 3-year change Capi.($)
+3.35%-0.42%-21.26%-53.41% 999M
-1.60%+0.61%-24.88%-22.59% 16.29B
-0.96%+0.97%-26.77%-31.73% 7.54B
+2.69%+2.44%-24.12%-11.95% 6.33B
+5.78%+3.17%-2.09%-27.83% 4.21B
-0.05%+0.73%-21.30%-36.59% 3.33B
-1.19%-1.37%-41.84%-24.97% 3.13B
+4.11%-1.46%+3.64%-35.92% 3.08B
-2.33%+2.34%+108.65% - 2.63B
-0.07%-1.65%-14.71%+3.22% 2.62B
Average +0.97%+265.01%-6.47%-26.86% 5.02B
Weighted average by Cap. +0.28%+333.40%-14.63%-24.31%

Financials

2026 *2027 *
Net sales 18.05B 2.67B 2.32B 2.16B 1.98B 3.73B 255B 3.79B 25.38B 9.96B 128B 10.04B 9.82B 425B 19.16B 2.84B 2.46B 2.3B 2.1B 3.96B 271B 4.02B 26.94B 10.57B 135B 10.66B 10.43B 451B
Net income 545M 80.79M 69.94M 65.38M 59.75M 113M 7.71B 114M 767M 301M 3.85B 303M 297M 12.84B 650M 96.29M 83.36M 77.91M 71.21M 134M 9.18B 136M 914M 359M 4.59B 362M 354M 15.3B
Net Debt -1.34B -199M -172M -161M -147M -277M -18.94B -281M -1.88B -739M -9.47B -746M -729M -31.55B -1.63B -242M -209M -196M -179M -337M -23.05B -342M -2.29B -900M -11.53B -907M -888M -38.4B
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
10/08/26 CNY 11.74 +3.35% 14,413,377
07/08/26 CNY 11.36 +0.44% 8,481,300
06/08/26 CNY 11.31 -0.09% 10,272,502
05/08/26 CNY 11.32 -1.82% 8,202,800
04/08/26 CNY 11.53 -2.21% 7,960,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.74CNY
Average target price
14.86CNY
Spread / Average Target
+26.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock